Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-30 | New | $25,244,903 | $25,244,903 | Other | 06b | SEC link |
| 2025-02-18 | New | $13,000,005 | $13,000,005 | Equity Only | 06b | SEC link |
| 2025-01-22 | New | $7,000,001 | $7,000,001 | Equity Only | 06b | SEC link |
| 2025-01-22 | New | $8,600,008 | $8,600,008 | Equity Only | 06b | SEC link |
| 2024-06-20 | New | $1,762,502 | $1,762,502 | Equity Only | 06b | SEC link |
| 2020-01-07 | New | $0 | $0 | Other | 06b | SEC link |
| 2020-01-07 | New | $0 | $0 | Other | 06b | SEC link |
| 2020-01-07 | New | $0 | $0 | Other | 06b | SEC link |
| 2019-02-05 | New | $31,250 | $31,250 | Other | 06b | SEC link |
| 2016-12-13 | New | $397,000,000 | $397,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| David Ben Naim | Executive |
| Yoseph Bornstein | Director |
| Scott Burell | Director |
| Juan Diaz Cartelle | Executive |
| Juan Diaz Cartelle | Executive |
| Harel Gadot | Director, Executive |
| Yehezkel Himelfarb | Executive |
| Pratipatti Laxminarain | Director |
| Prattipati Laxminarain | Director |
| Martin Madden | Director |
| Solomon Mayer | Director |
| David Ben Naim | Executive |
| Simon Sharon | Executive |
| Moshe Shoham | Director |
| Aileen Stockburger | Director |
| Rachel Vaknin | Executive |
| Yoav Waizer | Director |
| Tal Wenderow | Director |
| David Wilson | Director |